GlassScriptPhysician profile
Stephen David Lasday
NPI 1871530378
$6,131.41
in general payments reported to CMS, 2019-2025
47 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $710 · 2021: $934 · 2022: $875 · 2023: $1,744 · 2024: $578 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,713.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epsfl, LLC | $882.42 | 2023 | |
| Smith+Nephew, INC. | $773.51 | 2019-2025 | Grafix Pl, Stravix, Grafix |
| Organogenesis INC. | $701.12 | 2019-2025 | Puraply, Affinity, Via Matrix |
| Stryker Corporation | $497.66 | 2019-2023 | Prophecy |
| Horizon Therapeutics Plc | $361.55 | 2019-2023 | Krystexxa |
| Kerecis Limited | $305.45 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $217.50 | 2020-2023 | Activ.A.C. Ion Progress, Promogran Prisma |
| Paratek Pharmaceuticals, INC. | $207.41 | 2021-2023 | Nuzyra |
| Orthofix Medical, INC. | $189.22 | 2019-2023 | Physio-Stim |
| Keswick Pharmaceuticals LLC | $188.04 | 2019 | |
| Wright Medical Technology, INC. | $161.57 | 2019-2020 | |
| Reddress USA, INC. | $149.67 | 2024 | |
| Inari Medical, INC. | $148.40 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| In2bones USA, LLC | $118.17 | 2022 | |
| Vaporox, INC. | $108.87 | 2023 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $86.85 | 2020 | |
| Nevro Corp. | $81.47 | 2023-2024 | Senza |
| Aroa Biosurgery Incorporated | $75.01 | 2019-2025 | |
| Convatec INC. | $74.89 | 2023 | |
| Kedrion Biopharma, INC. | $73.53 | 2025 | Gammaked, Rhogam Ultra-Filtered Plus, Koate |
| Musculoskeletal Transplant Foundation INC. | $65.84 | 2019-2023 | |
| Fidia Pharma USA INC. | $52.48 | 2020-2025 | |
| Depuy Synthes Sales INC. | $52.37 | 2019-2020 | |
| Coastal Medical Technologies LLC | $48.76 | 2024-2025 | |
| Grt US Holding, INC. | $47.77 | 2020-2022 | |
| Integra Lifesciences Corporation | $47.03 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Averitas Pharma INC. | $37.62 | 2024 | Qutenza |
| Bioventus LLC | $34.27 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Tactile Systems Technology INC | $28.73 | 2020-2021 | |
| Biocomposites INC | $27.43 | 2019 | |
| Medela LLC | $25.91 | 2022 | |
| Djo, LLC | $21.90 | 2024 | Cmf |
| Reprise Biomedical, INC. | $21.42 | 2023 | Miro3d |
| Acera Surgical, INC. | $20.74 | 2023 | Restrata Wound Matrix |
| Hydrofera LLC | $19.88 | 2021 | |
| Triad Life Sciences INC. | $19.56 | 2022 | |
| Innovation Technologies INC | $17.78 | 2021 | |
| Sandoz INC. | $16.67 | 2020 | |
| Sanara Medtech INC. | $16.01 | 2023 | Celleraterx |
| Hartmann USA, INC. | $14.82 | 2020 | |
| Omeza LLC | $14.49 | 2023 | |
| Arthrosurface Incorporated | $14.33 | 2019 | |
| Melinta Therapeutics, LLC | $12.94 | 2019 | |
| Merck Sharp & Dohme LLC | $12.81 | 2019 | |
| Baxter Healthcare | $12.80 | 2020 | |
| Nabriva Therapeutics, Plc | $12.43 | 2020 | |
| Orpyx Medical Technologies US INC. | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lasday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.